Kerstin Junker

25PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersHaematological tumoursBioinformatic methods developmentMolecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Sep 09, 2026
Integrating NECTIN4 Amplification With Membranous Nectin-4 Expression to Develop a Scoring System for Predicting Enfortumab Vedotin Response in Urothelial Carcinoma.

|Dec 04, 2025
[The WHO Classification of Renal Cell Tumours: Implications for Personalised Treatment Decisions and Accurate Detection of Hereditary Renal Cell Carcinomas].

Marieta Ioana Toma, Roman-Ulrich Müller, Viktor Grünwald

|Jul 28, 2025
[Penile carcinoma: the importance of histological classification and new treatment strategies].

August Fiegl, Jan Niklas Mink, Kerstin Junker

|Feb 10, 2025
Machine Learning Accurately Predicts Muscle Invasion of Bladder Cancer Based on Three miRNAs.

Lea Eckhart, Sabrina Rau, Markus Eckstein

|May 02, 2024
Molecular and functional characterization of reversible-sunitinib-tolerance state in human renal cell carcinoma.

Angela Zaccagnino, Bozhena Vynnytska-Myronovska, Michael Stöckle

|Apr 24, 2024
NECTIN4 Amplification Is Frequent in Solid Tumors and Predicts Enfortumab Vedotin Response in Metastatic Urothelial Cancer.

Niklas Klümper, Ngoc Khanh Tran, Stefanie Zschäbitz

Pageof 5

Frequent Collaborators

4 joint publications

Philip Zeuschner

3 joint publications

Vsevolod Matveev

3 joint publications

Viktor Grünwald

2 joint publications

Thomas Büttner